Physicians’ knowledge and attitude regarding bisphosphonates-related adverse events: An observational study

Table 3 Univariate analyses of factors associated with the level of knowledge

Independent variables	Knowledge score (mean ± SD)	n	P-value
Professional position			0.232
Professor	8.82 ± 2.83	17
Attending physician	8.65 ± 2.57	54
Fellowship resident	7.93 ± 2.90	86
Department affiliation			< 0.0001a
Medical	8.92 ± 2.55	114
Surgical	6.56 ± 2.69	43
Department affiliation			< 0.0001a
Rheumatology	10.62 ± 2.83	8
Oncology	10.10 ± 1.77	20
Nephrology	9.70 ± 2.63	10
Endocrinology	9.45 ± 2.51	11
Internal medicine	8.21 ± 2.48	29
Family medicine	8.08 ± 2.52	36
Orthopedics	7.38 ± 3.09	21
Gynecology	5.77 ± 2.02	22
Age			0.213
< 30 yr	7.91 ± 2.87	80
30-50 yr	8.53 ± 2.77	55
> 50 yr	8.95 ± 2.46	22
Gender			0.016a
Male	7.84 ± 2.63	95
Female	8.94 ± 2.91	62
No. of patients attended per day			0.874
< 10 patients	8.29 ± 2.84	52
10-20 patients	8.32 ± 2.89	65
> 20 patients	8.03 ± 2.42	34
No. of medical sales representatives received per week			0.149
0	7.55 ± 2.60	20
< 10	7.98 ± 2.76	86
10-20	8.91 ± 2.62	34
> 20	9.07 ± 2.99	14
Time consumed for patients care			0.906
< 25%	8.25 ± 2.06	4
25%-50%	8.00 ± 2.77	37
51%-75%	8.43 ± 2.88	68
> 75%	8.25 ± 2.75	44
Time consumed for academic work			0.171
< 25%	8.23 ± 2.78	57
25%-50%	8.42 ± 2.80	76
51%-75%	7.25 ± 2.54	16
> 75%	10.50 ± 1.91	4
BP prescription			0.001a
Yes	8.78 ± 2.69	108
No	7.16 ± 2.70	49
No. of BP prescriptions delivered per month			0.006a
≤ 5 prescriptions	8.27 ± 2.64	73
6-10 prescriptions	9.70 ± 2.46	27
> 10 prescriptions	10.86 ± 2.48	7
Most frequent form of BP prescribed			0.033a
Oral form	8.48 ± 2.73	87
Intravenous form	9.90 ± 2.22	20
No. of patients on BP attended per month			< 0.0001a
0 patient	6.64 ± 2.06	11
1-5 patients	7.85 ± 2.52	81
6-10 patients	8.26 ± 2.81	34
> 10 patients	9.97 ± 2.99	31

^aP-value < 0.05 (level of significance). BP: Bisphosphonate.